Opioid-Sparing Hopes, Efficacy Worries Drive Inconclusive Advisory Cmte. On Durect's Posimir

FDA Advisory Committee Feature image
The Anesthetic and Analgesic Drug Products Advisory Committee voted 6-6 on whether to recommend approval of Durect's post-surgical pain relief product Posimir.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers